Advanced Enzyme Technologies 配当と自社株買い
配当金 基準チェック /46
Advanced Enzyme Technologies配当を支払う会社であり、現在の利回りは1.39%で、収益によって十分にカバーされています。
主要情報
1.4%
配当利回り
-0.009%
バイバック利回り
総株主利回り | 1.4% |
将来の配当利回り | 0.5% |
配当成長 | 32.1% |
次回配当支払日 | n/a |
配当落ち日 | n/a |
一株当たり配当金 | ₹5.100 |
配当性向 | 42% |
最近の配当と自社株買いの更新
Recent updates
After Leaping 26% Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Shares Are Not Flying Under The Radar
Aug 20We Think Shareholders Are Less Likely To Approve A Pay Rise For Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) CEO For Now
Jul 19Advanced Enzyme Technologies (NSE:ADVENZYMES) Has Affirmed Its Dividend Of ₹1.00
Jul 13Advanced Enzyme Technologies' (NSE:ADVENZYMES) Returns On Capital Not Reflecting Well On The Business
Apr 08Advanced Enzyme Technologies (NSE:ADVENZYMES) Will Want To Turn Around Its Return Trends
Sep 23Advanced Enzyme Technologies (NSE:ADVENZYMES) Could Be Struggling To Allocate Capital
Feb 03Advanced Enzyme Technologies (NSE:ADVENZYMES) Will Want To Turn Around Its Return Trends
Aug 11With EPS Growth And More, Advanced Enzyme Technologies (NSE:ADVENZYMES) Is Interesting
May 13Returns On Capital At Advanced Enzyme Technologies (NSE:ADVENZYMES) Paint A Concerning Picture
Mar 28The Advanced Enzyme Technologies (NSE:ADVENZYMES) Share Price Has Gained 185%, So Why Not Pay It Some Attention?
Mar 13Don't Ignore The Fact That This Insider Just Sold Some Shares In Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)
Feb 21Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Feb 18I Built A List Of Growing Companies And Advanced Enzyme Technologies (NSE:ADVENZYMES) Made The Cut
Feb 03What Kind Of Investors Own Most Of Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)?
Jan 19What Do The Returns On Capital At Advanced Enzyme Technologies (NSE:ADVENZYMES) Tell Us?
Dec 28The Advanced Enzyme Technologies (NSE:ADVENZYMES) Share Price Has Gained 114%, So Why Not Pay It Some Attention?
Dec 13Have Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Insiders Been Selling Their Stock?
Nov 28Are Strong Financial Prospects The Force That Is Driving The Momentum In Advanced Enzyme Technologies Limited's NSE:ADVENZYMES) Stock?
Nov 20Here's Why I Think Advanced Enzyme Technologies (NSE:ADVENZYMES) Might Deserve Your Attention Today
Nov 05What You Need To Know About Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) Investor Composition
Oct 21決済の安定と成長
配当データの取得
安定した配当: 配当金の支払いは安定していますが、 ADVENZYMESが配当金を支払っている期間は 10 年未満です。
増加する配当: ADVENZYMESの配当金は増加していますが、同社は7年間しか配当金を支払っていません。
配当利回り対市場
Advanced Enzyme Technologies 配当利回り対市場 |
---|
セグメント | 配当利回り |
---|---|
会社 (ADVENZYMES) | 1.4% |
市場下位25% (IN) | 0.3% |
市場トップ25% (IN) | 1.2% |
業界平均 (Chemicals) | 0.7% |
アナリスト予想 (ADVENZYMES) (最長3年) | 0.5% |
注目すべき配当: ADVENZYMESの配当金 ( 1.39% ) はIndian市場の配当金支払者の下位 25% ( 0.25% ) よりも高くなっています。
高配当: ADVENZYMESの配当金 ( 1.39% ) はIndian市場 ( 1.15% ) の配当支払者の中で上位 25% に入っています。
株主への利益配当
収益カバレッジ: ADVENZYMESの 配当性向 ( 41.6% ) はかなり低いため、配当金の支払いは利益によって十分にカバーされます。
株主配当金
キャッシュフローカバレッジ: ADVENZYMESは合理的な 現金配当性向 ( 63.1% ) を備えているため、配当金の支払いはキャッシュフローによって賄われます。